You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR ESTAZOLAM


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for estazolam

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00347295 ↗ Randomised, Double-blind Study to Investigate the Safety and Efficacy of Brotizolam in Insomnia Outpatients. Completed Boehringer Ingelheim Phase 3 2006-06-01 To investigate the efficacy and safety of Brotizolam in the treatment of patients with insomnia in comparison with that of Estazolam
NCT00956319 ↗ A Study to Evaluate Efficacy and Safety of Zolpidem Modified Release Formulation in Insomnia Patients Completed Astellas Pharma Inc Phase 4 2009-05-01 The purpose of the study is to investigate the efficacy and safety of zolpidem modified release (MR) tablet using estazolam (Eurodin) as a comparative drug in patients with primary insomnia.
NCT03708341 ↗ Exogenous Melatonin in Intensive Care Unit Chronodisruption Unknown status Saint-Joseph University Phase 3 2018-11-15 To this day, a small number of studies have evaluated the effect of melatonin on the modifications of the characteristics of sleep in critical care units, with mostly a small studied population. However, no study has been realized on a large population, nor has it evaluated the association between genetic factors and response to treatment (melatonin), hence the originality of our study. In our study we hypothesized that systematic melatonin usage in ICU can ameliorate the total sleep time and the fragmentation index and can decrease the confusion related to sleep deprivation.
NCT03997058 ↗ Observation on the Effect of Auricular Acupoint Pressing on Insomnia and Adverse Events in MHD Active, not recruiting Haitao Tu Phase 4 2019-03-01 Maintenance hemodialysis (MHD) is one of the most important treatments for patients with end-stage renal failure. Studies have found that insomnia is widespread in MHD patients, affecting their quality of life. Auricular acupoint pressing is an effective traditional Chinese medicine treatment for insomnia. This study compared the effects of auricular acupoint pressing and oral estazolam on insomnia in patients with MHD, and evaluated the possibility of auricular acupoint pressing to reduce the incidence of adverse events by improving insomnia in patients with MHD, and to explore the insomnia of MHD patients treated with TCM characteristics. The role and efficacy provide a basis for the treatment of sleep disorders by Chinese medicine.
NCT03997058 ↗ Observation on the Effect of Auricular Acupoint Pressing on Insomnia and Adverse Events in MHD Active, not recruiting The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine Phase 4 2019-03-01 Maintenance hemodialysis (MHD) is one of the most important treatments for patients with end-stage renal failure. Studies have found that insomnia is widespread in MHD patients, affecting their quality of life. Auricular acupoint pressing is an effective traditional Chinese medicine treatment for insomnia. This study compared the effects of auricular acupoint pressing and oral estazolam on insomnia in patients with MHD, and evaluated the possibility of auricular acupoint pressing to reduce the incidence of adverse events by improving insomnia in patients with MHD, and to explore the insomnia of MHD patients treated with TCM characteristics. The role and efficacy provide a basis for the treatment of sleep disorders by Chinese medicine.
NCT05452577 ↗ Treatment of Chronic Insomnia According to Yin Yang Theory and Its Correlation With Circadian Rhythm Recruiting The First Affiliated Hospital with Nanjing Medical University N/A 2021-01-22 The purpose of this study is to assess the safety and efficacy of Traditional Chinese medicine (TCM) according to Yin Yang theory for treatment of chronic insomnia .
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for estazolam

Condition Name

Condition Name for estazolam
Intervention Trials
Sleep Initiation and Maintenance Disorders 3
Intensive Care Psychosis 1
Primary Insomnia 1
Renal Dialysis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for estazolam
Intervention Trials
Sleep Initiation and Maintenance Disorders 4
Mental Disorders 1
Sleep Deprivation 1
Psychotic Disorders 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for estazolam

Trials by Country

Trials by Country for estazolam
Location Trials
China 3
Lebanon 1
Taiwan 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for estazolam

Clinical Trial Phase

Clinical Trial Phase for estazolam
Clinical Trial Phase Trials
Phase 4 2
Phase 3 2
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for estazolam
Clinical Trial Phase Trials
Completed 2
Recruiting 1
Unknown status 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for estazolam

Sponsor Name

Sponsor Name for estazolam
Sponsor Trials
Boehringer Ingelheim 1
Astellas Pharma Inc 1
Saint-Joseph University 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for estazolam
Sponsor Trials
Other 4
Industry 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.